Literature DB >> 10611103

HLA and Mooren's ulceration.

C J Taylor1, S I Smith, C H Morgan, S F Stephenson, T Key, M Srinivasan, E Cunningham, P G Watson.   

Abstract

BACKGROUND: Mooren's ulcer is a progressive intractable destructive peripheral ulceration of the cornea, probably of autoimmune aetiology. The disease is rare in the northern hemisphere but is more common in southern and central Africa and the Indian subcontinent. Although rare, its predominance in certain racial groups and their second generation migrants worldwide indicates a genetic as well as a geographic predisposition. The highly polymorphic human leucocyte antigens (HLA) confer genetic susceptibility to several autoimmune disorders. Therefore, a possible link between Mooren's ulcer and HLA type was investigated.
METHODS: Patients (n=22) with non-infective destructive peripheral corneal inflammatory disease were recruited worldwide. Differential diagnosis confirmed Mooren's ulceration in 12 cases. HLA typing (HLA-A, B, C, DRB, DQB) was performed by serology and PCR using sequence specific primers. The patients came from varied ethnic backgrounds and their HLA typing results were compared with published data from ethnically matched control populations.
RESULTS: Of the 12 patients with Mooren's ulcer, 10 (83%) were HLA-DR17(3) positive (including all nine patients of Asian, Indonesian, and black African origin), and 10 (83%) were HLA-DQ2 positive. The frequency of HLA-DR17(3) and DQ2 was higher in the Mooren's ulcer group compared to published data from ethnically matched control populations, where the expected antigen frequencies range between 5% and 40%.
CONCLUSION: These results suggest a possible association between HLA-DR17(3) and/or DQ2 and susceptibility to Mooren's ulcer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10611103      PMCID: PMC1723219          DOI: 10.1136/bjo.84.1.72

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  Mooren ulcer in South India: serology and clinical risk factors.

Authors:  M E Zegans; M Srinivasan; T McHugh; J P Whitcher; T P Margolis; T Lietman; J C Jennette; E T Cunningham
Journal:  Am J Ophthalmol       Date:  1999-08       Impact factor: 5.258

2.  Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP).

Authors:  M Bunce; C M O'Neill; M C Barnardo; P Krausa; M J Browning; P J Morris; K I Welsh
Journal:  Tissue Antigens       Date:  1995-11

Review 3.  Mooren's ulcer: current concepts in management.

Authors:  V S Sangwan; P Zafirakis; C S Foster
Journal:  Indian J Ophthalmol       Date:  1997-03       Impact factor: 1.848

4.  Management of Mooren's ulceration.

Authors:  P G Watson
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

5.  DR "low-resolution" PCR-SSP typing--a correction and an up-date.

Authors:  O Olerup; H Zetterguist
Journal:  Tissue Antigens       Date:  1993-01

6.  Cloning and sequence analysis of human and bovine corneal antigen (CO-Ag) cDNA: identification of host-parasite protein calgranulin C.

Authors:  J D Gottsch; W J Stark; S H Liu
Journal:  Trans Am Ophthalmol Soc       Date:  1997

7.  Cloning and expression of bovine corneal antigen cDNA.

Authors:  J D Gottsch; S H Liu
Journal:  Curr Eye Res       Date:  1997-12       Impact factor: 2.424

8.  HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours.

Authors:  O Olerup; A Aldener; A Fogdell
Journal:  Tissue Antigens       Date:  1993-03

9.  Cloning and expression of human corneal calgranulin C (CO-Ag).

Authors:  J D Gottsch; S H Liu
Journal:  Curr Eye Res       Date:  1998-09       Impact factor: 2.424

10.  Autoimmunity to a cornea-associated stromal antigen in patients with Mooren's ulcer.

Authors:  J D Gottsch; S H Liu; J B Minkovitz; D F Goodman; M Srinivasan; W J Stark
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-07       Impact factor: 4.799

View more
  4 in total

1.  Association of HLA type and Mooren's Ulcer in Chinese in Taiwan.

Authors:  C-K Liang; K-H Chen; W-M Hsu; K-H Chen
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

2.  Mooren's ulcer resolved with campath-1H.

Authors:  J van der Hoek; A Azuara-Blanco; K Greiner; J V Forrester
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

3.  Bilateral Mooren's ulcer in six patients: diagnosis, surgery and histopathology.

Authors:  Christos D Kalogeropoulos; Vassiliki D Malamou-Mitsi; Miltiadis B Aspiotis; Konstantinos G Psilas
Journal:  Int Ophthalmol       Date:  2004-01       Impact factor: 2.031

4.  Amniotic membrane transplantation ineffective as additional therapy in patients with aggressive Mooren's ulcer.

Authors:  Maurice Schallenberg; Henrike Westekemper; Klaus-Peter Steuhl; Daniel Meller
Journal:  BMC Ophthalmol       Date:  2013-12-17       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.